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INTRODUCTION
Since its initial clinical application in pediatric patients in
1990, radiofrequency catheter ablation (RFCA) has become
a viable option for the management of tachycardia in children
(1-5). In 2000, we began to use RFCA in the treatment of
children with tachycardia, and after our initial experience of
100 consecutive RFCA in children, we performed a retrospec-
tive study to elucidate the safety and efficacy of the procedure.
We also assessed the influence of congenital heart malforma-
tions and surgery on the efficacy and safety of RFCA. 
MATERIALS AND METHODS
Patients
From March 2000 to June 2004, we conducted electro-
physiological studies (EPS) on 144 patients in the Pediatrics
department of our institution. Prior to EPS, we planned con-
comitant RFCA for the treatment of symptomatic tachycardia
in 109 of these patients. Among these 109 patients, RFCA
was excluded as an option for 6 patients, as their parents re-
fused the procedure due to its relatively high complication
rate. These 6 cases included: one junctional ectopic tachycar-
dia with Ebstein anomaly, one concealed nodo-fascicular tract
with corrected transposition of great arteries, one multifocal
atrial tachycardia, one midseptal accessory pathway (AP), one
para-Hissian AP, and one patient whose AP had been rendered
inactive due to mechanical trauma. We attempted RFCA in
103 patients, and 3 patients who were 20 yr of age or older
were excluded from this study. We then conducted a retro-
spective evaluation of the 100 consecutive patients who had
undergone RFCA when younger than 20 yr of age.
Procedures
EPS and ablation were performed under conscious sedation,
using midazolam if the patient was younger than 13 yr of
age. Three of the patients required respiratory support with
concomitant endotracheal intubation, as one patient exhibited
persistent tachycardia with impending cardiogenic shock,
and the other two patients exhibited upper airway obstruc-
tions due to adenoid and tonsillar hypertrophy. In most of
the patients, two right femoral vein sheaths, two left femoral
vein sheaths, and one left femoral arterial line were installed.
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Pediatric Radiofrequency Catheter Ablation: Results of Initial 100 
Consecutive Cases Including Congenital Heart Anomalies
Radiofrequency catheter ablation (RFCA) has recently become a management option
for pediatric tachycardia. We reviewed the records of a total of 100 patients (aged 10
months to 19 yr) who had undergone RFCA, from March 2000 to June 2004. Types
of arrhythmia (age, acute success rate) were as follows: atrioventricular reentrant
tachycardia (AVRT, 9.0±3.7 yr, 66/67), atrioventricular nodal reentrant tachycardia
(AVNRT, 13±2.5 yr, 16/16), ectopic atrial tachycardia (6.4±3.3 yr, 5/5), junctional
ectopic tachycardia (10 month, 1/1), ventricular tachycardia (12±4.9 yr, 6/6), post-
surgical intraatrial reentrant tachycardia (15.6±4.1 yr, 2/3), twin node tachycardia
(4 yr, 0/1), and His bundle ablation (9 yr, 1/1). The age of AVNRT was older than
that of AVRT (p=0.002). Associated cardiac disease was detected in 17 patients,
including 6 univentricular patients, and 3 Ebstein’s anomaly patients. RFCA for mul-
tiple accessory pathways required longer fluoroscopic times than did the single acces-
sory pathway (53.9±4.8 vs. 36.2±24.1 min; p=0.03), and was associated with a
higher recurrence rate (3/9 vs. 3/53; p=0.03). Regardless of the presence or absence
of cardiac diseases, the overall acute success rate was 97% without major compli-
cations, the recurrence rate was 8.2%, and the final success rate was 97%. This
experience confirmed the efficacy and safety of RFCA in the management of tachy-
cardia in children. 
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EP catheters were introduced into the high right atrium, the
His bundle area, the right ventricle, and the coronary sinus.
High right atrial catheter was later replaced by an ablation
catheter. All studies were performed guided by biplane fluo-
roscopy. Angiographies were taken prior to ablation if the
patient had a congenital heart disease or ectopic tachycardia.
Electrode catheter size varied from 5 F to 7 F (St. Jude Medi-
cal, Daig Division, Minnetonka, MN, U.S.A.) according to
the individual patient. After the diagnostic EP study, map-
ping and ablation using an ablation catheter (Boston Scien-
tific EP Technology, San Jose, CA, U.S.A.) was performed.
All induced tachycardias were found to be identical to clini-
cal tachycardia. When appropriate sites had been identified,
radiofrequency energy was delivered by a temperature-con-
trolled generator. Bolus dose of heparin (100 unit/kg) was
administered intravenously prior to the initiation of ablation
procedure. The ablation was considered successful if the fol-
lowing conditions were fulfilled: loss of abnormal pathway
for atrioventricular reentrant tachycardia or noninducibility
of tachycardia, followed by the termination of tachycardia
during ablation for primary atrial tachycardia, ventricular
tachycardia, and scar-related atrial flutter. After ablation, the
patient was hospitalized overnight, and a continuous heparin
infusion was implemented for all patients undergoing left
heart ablations. Activated partial thromboplastin time was
maintained, at a level of twice the normal range. Low doses
of aspirin were also administered for a month to the cases in
which a left heart lesion had been made. All patients were
followed up at intervals of 1, 3, 6 and 12 month(s). 
Statistics
Values are expressed as the mean±standard deviation. Uni-
variate comparisons of continuous variables were conducted
using the Student’s t test. Univariate analyses of the differences
in proportion between the two groups were accomplished
using the  2 test.
RESULTS 
Patient characteristics
The age of the total 100 patients ranged from 10 months
to 19 yr, with a mean of 10.2±4.1 yr. Twelve of the patients
were less than 5 yr old. The age distributions are shown in
Fig. 1. The male to female ratio was 52:48. The indications
for RFCA are listed in Table 1. Tachycardia-induced cardiomyo-
pathy was observed in 5 patients (4 patients with ectopic
atrial tachycardia, 1 patient with idiopathic left ventricular
tachycardia). Ventricular function recovered after successful
RFCA in all patients by 3 months after the procedure. One
infant, who was 10 months old and the youngest patient of
this series, presented with fetal tachycardia. The nature of
this patient’s tachycardia was determined to be congenital
junctional ectopic tachycardia. This tachycardia was poorly
controlled by antiarrhythmic drugs, including amiodarone
and flecainide. Eventually, this patient became hypotensive
and acidotic, so we performed emergent RFCA. Among 100
total RFCA cases, the most frequent indication was that the
patient or parents preferred definitive RFCA management
to chronic medication for the treatment of recurrent symp-
tomatic tachycardia. 
Types of arrhythmia 
The types of tachycardia are summarized in Table 2, 3. The
most frequently observed type of tachycardia was atrioven-
tricular reentrant tachycardia (AVRT), which was observed
in 67 patients. Wolff-Parkinson-White (WPW) syndrome
was also associated with induced AVRT, and seen in 35 pa-
tients. In only three of these patients, antidromic tachycardia
was also induced during EPS. Two of the 67 AVRT patients
exhibited characteristics of permanent junctional reciprocating
tachycardia, with a slowly conducting accessory pathway (AP)
in the posteroseptal area. Multiple accessory pathways were
found in 9/67 patients (13.4%). Multiple AP were document-
ed by the following observations: (a) changed retrograde ven-
triculo-atrial conduction patterns during the same tachycar-
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Fig. 1. This bar graph shows the age distributions of the patients
undergoing radiofrequency catheter ablation. The age of the total
of 100 patients ranged from 10 months to 19 yr, with a mean of 10.2
±4.1 yr. The failed or recurred cases, as well as the major congeni-
tal heart disease patients were distributed nonspecifically through-
out the entire age range. 
Failed or recurred cases
Major congenital heart disease
Indications No. of patients
Syncope or presyncope 4
Tachycardia induced cardiomyopathy 5
Persistent tachycardia or frequent recurrence  21
with medication
Recurrent symptomatic tachycardia, parent’s  63
choice (age>5 yr)
Arrhythmia treatment before surgery 5
Drug side effect 2
Table 1. Indications of radiofrequency catheter ablation in children
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dia, (b) multiple patterns of pre-excitation on surface ECGs,
and (c) two or more separate successful ablation sites, belong-
ing to different divisions of the mitral or tricuspid valve annu-
lus (Fig. 2).
AV nodal reentrant tachycardia (AVNRT) was detected
in 16 patients. We performed RFCA in 16 patients for other
tachycardias: primary atrial tachycardia, junctional ectopic
tachycardia (JET), ventricular tachycardia (VT) and intraatrial
reentrant tachycardia (IART). 
Results of RFCA in normal or trivial cardiac anomaly
AVRT in normal or trivial structural anomaly
AVRT was induced in 62 patients with normal or trivial
structural anomalies. Cardiomyopathy or myocardial dysplasia
(n=4), cardiac tumor presumed to be rhabdomyoma (n=1),
and simple septal defects (n=2) exerted no influence on the
technique and results of the procedure. The AP distribution,
determined by a successful ablation site, was illustrated in
Fig. 2. Multiple AP was counted separately. RF ablation for
multiple AP required longer fluoroscopic times than did that
for single AP patients (53.9±4.8 vs. 36.2±24.1 min; p=
0.03). In 45 patients, the accessory pathway was found in the
left heart, around the mitral valve annulus. We approached
in an antegrade manner, via the patent foramen ovale in 5
patients, and utilized a Brockenbrough trans-septal needle
perforation of the interatrial septum in 40 patients. Only one
patient required a retrograde submitral approach, because her
posteroseptal accessory pathway could not be eliminated by
both right and left atrial approaches. RF ablation failed in
only one patient, who exhibited concealed para-Hissian AP.
The initial RFCA success rate was 61/62 (98.4%). The recur-
rence rate was 3/9 (33.3%) for the multiple AP patients, and
3/53 (5.7%) for the single AP patients (p=0.03). There were
no differences detected in the success rates or recurrence rates
with regard to right side and left side APs (Fig. 2). Failed and
recurred cases are summarized in Table 4.
Slow pathway ablation in AV nodal reentrant tachycardia (AVNRT)
AVNRT was detected in 16 patients. The age of the AVNRT
cases was older than that of the AVRT cases (13±2.5 vs. 9.0
±3.7 yr respectively; p=0.002). Radiofrequency ablation by
electroanatomic guide was performed via a posterior approach.
We achieved successful slow pathway ablation or slow path-
way modification in all 16 patients. The fluoroscopic time
for ablation was 28.7±9.9 min, which appeared to be shorter
than that required for AVRT ablation. However, this differ-
ence did not reach statistical significance (p=0.07). AV node
conduction was determined to be intact after ablation, and
no recurrence was observed in any of the patients.
Tachycardia
No. of
cases
Age
(yr)
Acute
success
Recurrence Final 
success
AVRT 68 9.0±3.7  66/67 4/56 single AP 66/67
3/9 multiple APs
AVNRT 16 13.0±2.5 16/16 0/16 16/16
Ectopic atrial  5 6.4±3.3 5/5 0/5 5/5
tacycardia
IART 3 16.0±3.6 2/3 1/2 1/3
Junctional ectopic   1 0.8 1/1 0/1 1/1
tachycardia
Twin node  1 4 0/1 1/1
tachycardia
JET+IART 1 11 1/1 0/1 1/1
(AV node ablation)
Ventricular 6 12.1±4.9 6/6 0/6 6/6
tachycardia
Total 100 10.2±4.1 97/100 8/97 97/100
Table 2. Tachycardia types and results of ablation procedure
AV, Atrio-ventricular; AVRT, Atrioventricular reentrant tachycardia; AVNRT,
Atrioventricular nodal reentrant tachycardia; IART, intraatrial reentrant
tachycardia; JET+IART, junctional ectopic tachycardia and intraatrial
reentrant tachycardia; AP, accessory pathway.
Disease Tachycardia No. of cases
Not-repaired
Idiopathic Cardiomyopathy AVRT 2
Myocardial dysplasia Ectopic atrial tacycardia 1
AVRT 1
Ebstein’s anomaly AVRT 3
Atrial septal defect AVNRT 1
Cardiac Tumor AVRT 1
Repaired 
Functional single ventricle
Cavopulmonary shunt state AVRT 2
AV valve replacement IART 1
Fontan operation AVRT 1
IART 1
IART+JET 1
Tetralogy of Fallot  IART 1
Ventricular septal defect  AVRT 1
Total 17
Table 3. Associated cardiac disease and tachycardia
The same abbreviations as Table 2.
Fig. 2. This diagram depicts the accessory pathway locations of
67 patients with atrioventricular reentrant tachycardia. The multi-
ple pathways were marked separately in this figure. The left lat-
eral atrioventricular groove was the most frequent location of the
accessory pathway. TV, tricuspid valve; MV, mitral valve.
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Ectopic atrial tachycardia 
Ectopic atrial tachycardia was demonstrated in 5 patients,
in an age range of between 3 to 10 and a mean of 6.4±3.3
yr. Four of these patients exhibited decreased left ventricular
ejection fractions, as well as chamber enlargement. Three
patients exhibited persistent tachycardia despite medical treat-
ment. RFCA was performed during the tachycardia, and guid-
ed by both unipolar and bipolar mapping signals in all cases.
Successful foci exhibited earlier activation, by 19±8 msec,
than at the beginning of the ectopic P wave. Ectopic foci were
located in the right atrial appendage in 2 patients, in the crista
terminalis in 2 patients, and left atrial appendage in 1 patient.
We achieved the successful ablations of ectopic foci in all
patients, without recurrence. Left ventricular function recov-
ered after ablation in all four patients with tachycardia-induced
cardiomyopathy. 
VT in normal heart
Six patients (age: 12±4.9 yr) exhibited idiopathic VT.
None exhibited structural heart disease. One patient suffered
from tachycardia induced cardiomyopathy. Four patients had
idiopathic VT in the left ventricle, and two in the right ven-
tricle. RF ablation was performed for LV ventricular tachy-
cardia via Purkinje signal mapping, and successful ablations
were achieved at the posteroseptum on the left ventricular
side. For two patients, whose VT originated from the RV out-
flow tract, VT pace-mapping proved helpful in the successful
ablation. None of the six patients exhibited VT recurrence
after ablation.
Junctional ectopic tachycardia
One ten-month-old male infant exhibited persistent junc-
tional ectopic tachycardia. We performed emergent RFCA,
as the patient was in shock state in spite of antiarrhythmic
medication. Because there was no retrograde atrial conduction
through AV node during the tachycardia, we attempted an
empirical RF ablation. Tachycardia was eliminated by the
application of 50℃ RF energy to the mid-part of the Koch’s
triangle. A very transient complete heart block was observed,
but fortunately, AV nodal conduction recovered within 6 sec.
This patient has exhibited normal AV node function without
any recurrence of tachycardia for 2-yr follow-up. 
Results of RFCA with associated heart disease 
Among 100 total patients, associated cardiac disease was
detected in 17 patients (Table 2). Ten of these patients had sig-
nificant cardiac anomalies, which complicated both mapping
and ablation procedures. Three patients exhibited Ebstein’s
anomalies associated with AVRT, one patient had a repaired
tetralogy of Fallot with IART, and the remaining six patients
exhibited complex cardiac anomalies with single ventricle
physiology associated with AVRT (n=3), IART (n=2), and
IART coupled with focal junctional tachycardia (n=1). The
fluoroscopy time recorded during the RFCA procedure ap-
peared to be longer in patients with major congenital heart
disease than in those with normal or trivial heart anomalies
with weak statistical significance (51.4±37.6 vs. 34.3±15.2
Cardiac disease  Tachycardia characteristics Final Outcome
Failed cases
Normal structure Concealed paraHissian AP Well controlled by beta blocker for 4 yr
RI, CAVSD, s/p BCPS Twin AV node tachycardia  Cryoablation during Fontan operation, no recur for 2 yr
RI, CAVSD, s/p AVVR IART Amiodarone, expired after 1 yr due to heart failure
Recurred cases
RI, CAVSD, s/p Fontan   WPW, AVRT Reattempt to RFCA, success
Double inlet RV, s/p Fontan IART Sotalol, decreased frequency 
Tumor WPW, AVRT, multiple APs Reattempt to RFCA, success
Normal structure PJRT Reattempt to RFCA, success
Normal structure AVRT, multiple APs Reattempt to RFCA, success
Normal structure AVRT, multiple APs Reattempt to RFCA, success
Normal structure WPW, single left side AP Reattempt to RFCA, success
Normal structure WPW, single right side AP Reattempt to RFCA, success
Table 4. Failed or recurred cases
RI, right isomerism; CAVSD, complete atrioventricular septal defect; s/p BCPS, status post bi-directional cavopulmonary shunt; s/p AVVR, status post
common atrioventricular valve replacement; s/p Fontan, status post Fontan operation; WPW, Wolff Parkinson White syndrome; RFCA, radiofrequency
catheter ablation; otherwise the same abbreviations as Table 2.
No. of cases Times (min)
Normal or trivial heart anomaly  90 34.3±15.2
Major heart anomaly 10 51.4±37.6
Single accessory pathway 59 36.2±24.1
Multiple accessory pathways 9 53.9±4.8
AVRT 68 40.5±25.0
AVNRT 16 28.7±9.9
Ectopic atrial tachycardia  5 32.2±11.1
Ventricular tachycardia  6 33.0±10.1
IART 3 63.5±44.9
Total 100 38.3±22.6
Table 5. Fluoroscopic time
The same abbreviations as Table 2.744 E.-J. Bae, J.-E. Ban, J.-A. Lee, et al.
min respectively; p=0.06) (Table 5).
AVRT in congenital heart disease
Among 3 patients with Ebstein’s anomaly, two had WPW
syndrome. Atrioventricular accessory pathways were located
in the right posterior site in 3 of the patients. One patient
exhibited multiple pathways in the right posterior and right
midseptal area. All right posterior pathways were successfully
ablated at the electrical atrioventricular junction. The abla-
tion of accessory pathways in patients with functional single
ventricle was attempted in two of the patients. A 22-month
old patient with a double-inlet right ventricle was slated to
undergo a Fontan operation. RFCA was performed prior to
the Fontan operation, as we considered catheter access to the
AV groove to be limited after the completion of a Fontan
operation. Another 9-yr old girl with WPW syndrome, an
atrioventricular septal defect, and a double outlet right ven-
tricle had already undergone a fenestrated lateral tunnel-type
Fontan operation prior to RFCA. The initial RF attempt was
performed via a retrograde approach because we failed to get
the femoral venous access. Mapping of the accessory pathway
beneath the common AV valve was difficult, due to the atypi-
cal AV junctional position, using a conventional mapping
system. The anteriorly located accessory pathway was success-
fully ablated on the atrial side via retrograde approach. How-
ever, recurrence was noted on the next day, and symptomatic
tachycardia recurred 4 months after the performance of RFCA.
Finally, the accessory pathway was eliminated by the third
ablation procedure, which had been performed in an antegrade
manner, through the Fontan baffle fenestration.
Twin AV node-related tachycardia
One patient with right isomerism, complete atrioventric-
ular septal defect, and a double-outlet right ventricle, also
developed narrow QRS tachycardia by the single ventricular
extrastimulus. EPS revealed the presence of a twin AV node
(both anterior and posterior nodes) which provided the reentry
circuit. As the patient had been previously scheduled for a
Fontan operation, we planned a concomitant cryoablation in
the operating room following a few failed test RF ablations
around the posterior node.
Post-surgical IART
Three patients exhibited medically intractable postopera-
tive IART (15.6±4.1 yr old) These patients had previously
undergone a Fontan operation for a single inlet right ventri-
cle in one patient, a common AV valve replacement with a
bi-directional cavopulmonary shunt for right isomerism in
one patient, and a total correction of tetralogy of Fallot in
one patient. Concealed entrainment mapping during tachy-
cardia revealed that the critical isthmus was located in the
corridor between the surgical scar and the inferior vena cava
in two patients. In one patient, the IART exhibited a typical
counterclockwise periannular circuit around the tricuspid
valve. The initial success of RF ablation was achieved in two
patients. However, 3 months later, the IART recurred in one
Fontan patient, and this has been controlled, in part, by sotalol. 
AV node ablation in a Fontan patient with multiple intractable
tachycardia mechanisms
One lateral tunnel Fontan patient (double inlet right ven-
tricle with mitral valve hypoplasia) had frequent attacks of
focal junctional tachycardia, with simultaneous IART and
sinus node dysfunction. As this patient had had several episodes
of near syncope and also exhibited a tendency toward severe
sinus bradycardia followed by junctional ectopies or bouts
of IART, a DDDR pacemaker was implanted, and amiodarone
was prescribed. In spite of these measures, the patient contin-
ued to suffer from recurrent JT or IART. Although we had
planned to eliminate the arrhythmic focus, 2 types of rapidly-
conducting induced IART (cycle lengths of 262 msec and 259
msec and 1:1 AV conduction) and rapid JT appeared to be too
dangerous to map. Therefore, we decided to ablate or modify
the AV node. His bundle electrogram (HBE) was recorded
antegradely, via fenestration at the posterior AV groove. As
an initial attempt to modify the AV node did not result in
the abolition of the rapid JT, we attempted a second RFCA.
A complete AV block resulted 6 sec after a second ablation
attempt in the HBE recording site. This patient is now doing
well, with no symptoms related to tachycardia over 22 months,
and remains on sotalol with a pacemaker.
Complications of the procedure 
Three patients complained of transient chest pain after the
procedure. This chest pain did not appear to be associated
with ischemic ECG patterns or pericardial effusion. The chest
pain subsided spontaneously by the following day in all of
the patients. Transient complete right bundle branch block
was observed in 8 patients during the catheter work, and this
resolved itself within several minutes or hours. No patients
exhibited procedure-related valve dysfunctions, myocardial
perforation, or unpredicted heart blocks. There were also no
documented thromboembolic events related to the procedure
within one year of the procedure. 
DISCUSSION
RFCA has recently been accepted as a viable management
option for tachycardia, and the results of RFCA in pediatric
patients has improved substantially (6-9). Moreover, since
January 2004, Korean medical insurance has supported the
medical costs associated with the RFCA procedure, and there-
fore reports regarding the results and clinical impacts of this
procedure in the Korean pediatric population are currently
a matter of some necessity. This procedure needs to be proven
to be a measure of improved patient safety and outcomes.Pediatric Radiofrequency Catheter Ablation 745
The present report summarized the efficacy and limitation
of pediatric RFCA for the treatment of a variety of tachycar-
dia types, with or without congenital heart disease, in single
institute in Korea. At our institute, radiofrequency ablations
were performed according to the guidelines established by
the NASPE expert consensus conference (10). Most of our
patients (61%) underwent RFCA according to their desig-
nation as class IIB patients. These patients exhibited symp-
tomatic recurrent tachycardia (age >5 yr), and RFCA was
performed as an alternative to chronic antiarrhythmic therapy.
However, most would agree that successful RFCA yields greatly
beneficial results for both our patients and their parents. 
The special considerations for pediatric RFCA, as opposed
to the adult population, are as follows; (a) favorable natural
history of infantile tachycardia, (b) results of pediatric RFCA,
(c) associated heart disease, (d) information available from
studies in young animal models, (e) radiation safety consid-
erations, (f) complications of pediatric RFCA, (g) cost-effec-
tiveness analyses in the pediatric population, and (h) sedation
issues in the young. The natural history of pediatric tachycar-
dia is, in general, favorable (11). In young patients, especially
in infants, spontaneous remission is common. The manifested
accessory pathways noted during infancy disappear in about
70% of the patients during the follow-up period. However,
30-50% of patients may experience recurrence in later child-
hood (12, 13). Due to the generally favorable natural history
statistics, we performed AVRT ablation mostly in patients
who were 5 yr of age or older. All cases associated with the
performance of RFCA before 5 yr of age in our series exhib-
ited medically intractable tachycardia recurrences, or tachy-
cardia-induced cardiomyopathy. 
The success rate and recurrence of RFCA reported in this
series is comparable to those seen in previous reports (2, 4, 7-9).
The success rate of RFCA for the treatment of paroxysmal
supraventricular tachycardia, including AVRT and AVNRT,
with or without congenital heart disease was 82/83 (98.8%),
the recurrence rate was 7/83 (8.4%), and the ultimate success
rate following subsequent procedures was 82/83 (98.8%).
The success rate and recurrence rate of right side vs. left side
accessory pathways were similar. We experienced neither fail-
ure nor recurrence in patients with EAT, JET, and idiopathic
VT, although our study involved only a small number of such
cases. Our data also revealed that prolonged fluoroscopic time
was associated with multiple accessory pathways, or congeni-
tal heart anomalies. 
The management of patients suffering from congenital
heart disease may be complicated by serious arrhythmias, due
to WPW syndrome, or by atrial arrhythmias, including IART,
after cardiac surgery. Ablation techniques using radiofrequency
currents are presently revolutionizing the management of
arrhythmias. Several common features among patients suffer-
ing from congenital heart disease can complicate RFCA when
used as a treatment for supraventricular tachycardia, and might
be expected to reduce its acute and long-term efficacy, as well
as increasing the frequency of procedure-related complications.
The anatomical landmarks which are commonly used to deter-
mine the location of the AV node and the annulus of the atrio-
ventricular valves are often absent or distorted. Catheter
access may also prove to be very difficult, owing to surgical
interventions, systemic venous anomalies, and acquired venous
occlusion. Moreover, pulmonary and hemodynamic impair-
ment can increase the risks of the procedure (14-16). The
association between accessory pathways and Ebstein’s anoma-
lies has been well-documented. We performed successful
ablations at the electrical atrioventricular annulus of the tri-
cuspid valve. Multiphasic low intensity signals of diseased
atrialized ventricular myocardium could be discerned by cau-
tious and tedious atrial pacing, at Wenckebach block cycle
length. We also confirmed the relative difficulty of RF abla-
tion for the treatment of WPW syndrome after the comple-
tion of a Fontan operation. We agree that RFCA should be
recommended for patients with impending congenital heart
disease surgery, in cases in which vascular or chamber access
may be restricted after surgery (10). 
Recurrence tends to be observed within 3-6 months after
the ablation of the accessory pathways, and this held true in
our study as well. In children, the risks of radiofrequency
ablation appear, from the results of follow-up evaluations, to
be relatively low. Longer-term follow-up of children under-
going radiofrequency ablations will be necessary in order to
determine whether or not coronary abnormalities or serious
new arrhythmias are likely to develop.
IART is a common problem in patients with congenital
heart disease, especially after a successful Fontan procedure.
Relatively low success rates and high recurrence rates, have
been reported, especially after ablation guided by conventional
entrainment mapping techniques (17-19). However, in pa-
tients with successful RF ablation, the frequency of subsequent
events can be reduced. New electroanatomic 3-dimensional
mapping techniques will facilitate the precise mapping of
complicated reentrant circuits and scar zones (19). 
Twin AV node-related atrioventricular reentrant tachycar-
dia is quite a rare condition, and is usually associated with
heterotaxy syndrome or complicated complete atrioventric-
ular septal defect requiring Fontan-type palliation (20, 21).
As tachycardia in Fontan patients almost always induces seri-
ous hemodynamic compromise, aggressive management with
RFCA or surgical ablation during concomitant surgery should
be considered in any symptomatic tachycardia patients. Addi-
tionally, the natural course of twin AV node-related tachycar-
dia remains to be fully elucidated. 
In conclusion, regardless of the presence or absence of cardiac
anomalies, the overall acute success rate of pediatric RFCA
in our study was 97%, the recurrence rate was 8.2%, and the
final success rate was 97%. No major complications were
noted. This experience confirmed the efficacy and safety of
RFCA in the management of pediatric tachycardia patients.746 E.-J. Bae, J.-E. Ban, J.-A. Lee, et al.
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